REQUEST A DEMO
Total
USD $0.00
Search more companies

Gesk Pharma Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Toilet Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Pharmacies and Drug Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Gesk Pharma Cia.Ltda Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Gesk Pharma Cia.Ltda is an enterprise located in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on June 04, 2019. The latest financial highlights indicate a net sales revenue increase of 125.62% in 2023. Its’ total assets recorded a growth of 63.78%. The enterprise’s net profit margin decreased by 12.71% in 2023.

Headquarters
Av. Carapungo Oe8-26
Quito; Pichincha;

Contact Details: Purchase the Gesk Pharma Cia.Ltda report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gesk Pharma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Gesk Pharma Cia.Ltda report to view the information.
Incorporation Date:
June 04, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Gesk Pharma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
125.62%
Total operating revenue
125.61%
Operating profit (EBIT)
174.78%
EBITDA
170.04%
Net Profit (Loss) for the Period
-12.13%
Total assets
63.78%
Total equity
N/A
Operating Profit Margin (ROS)
4.81%
Net Profit Margin
-12.71%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
0.16%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?